nimotuzumab
biocon,daiichi sankyo,oncoscience
['improve', 'nimotuzumab', 'pancsm', 'pancreatic']
nimotuzumab plus gemcitabine improves survival in kras wild-type pancreatic cancer #asco22 #pancsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.